The global Gadobutrol (CAS 138071-82-6) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Gadobutrol (CAS 138071-82-6) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Gadobutrol (CAS 138071-82-6) market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Gadobutrol (CAS 138071-82-6) in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Gadobutrol (CAS 138071-82-6) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Bayer HealthCare Pharmaceuticals Inc.
SWAPNROOP DRUGS & PHARMACEUTICALS
Manus Aktteva Biopharma LLP
Jilin Tely Imp & Exp CO.,LTD
JinYan Chemicals (ShangHai) Co., Ltd.
BOC Sciences
LGM Pharma
Advanced Technology & Industrail Co., Ltd.
MedKoo Biosciences, Inc.
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
Single Dose Pre-filled Injections (7.5 mL, 10 mL, 15 mL)
Pharmacy Bulk Packages (30 mL and 65 mL)
Segment by Application
Adults
Children
Table of Contents Executive Summary 1 Industry Overview of Gadobutrol (CAS 138071-82-6) 1.1 Definition of Gadobutrol (CAS 138071-82-6) 1.2 Gadobutrol (CAS 138071-82-6) Segment by Type1.2.1 Global Gadobutrol (CAS 138071-82-6) Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL) 1.2.3 Single Dose Pre-filled Injections (7.5 mL, 10 mL, 15 mL) 1.2.4 Pharmacy Bulk Packages (30 mL and 65 mL) 1.3 Gadobutrol (CAS 138071-82-6) Segment by Applications1.3.1 Global Gadobutrol (CAS 138071-82-6) Consumption Comparison by Applications (2014-2025) 1.3.2 Adults 1.3.3 Children 1.4 Global Gadobutrol (CAS 138071-82-6) Overall Market1.4.1 Global Gadobutrol (CAS 138071-82-6) Revenue (2014-2025) 1.4.2 Global Gadobutrol (CAS 138071-82-6) Production (2014-2025) 1.4.3 North America Gadobutrol (CAS 138071-82-6) Status and Prospect (2014-2025) 1.4.4 Europe Gadobutrol (CAS 138071-82-6) Status and Prospect (2014-2025) 1.4.5 China Gadobutrol (CAS 138071-82-6) Status and Prospect (2014-2025) 1.4.6 Japan Gadobutrol (CAS 138071-82-6) Status and Prospect (2014-2025) 1.4.7 Southeast Asia Gadobutrol (CAS 138071-82-6) Status and Prospect (2014-2025) 1.4.8 India Gadobutrol (CAS 138071-82-6) Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Gadobutrol (CAS 138071-82-6) 2.3 Manufacturing Process Analysis of Gadobutrol (CAS 138071-82-6) 2.4 Industry Chain Structure of Gadobutrol (CAS 138071-82-6) 3 Development and Manufacturing Plants Analysis of Gadobutrol (CAS 138071-82-6) 3.1 Capacity and Commercial Production Date 3.2 Global Gadobutrol (CAS 138071-82-6) Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Gadobutrol (CAS 138071-82-6) 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Gadobutrol (CAS 138071-82-6) Production and Capacity Analysis 4.2 Gadobutrol (CAS 138071-82-6) Revenue Analysis 4.3 Gadobutrol (CAS 138071-82-6) Price Analysis 4.4 Market Concentration Degree 5 Gadobutrol (CAS 138071-82-6) Regional Market Analysis 5.1 Gadobutrol (CAS 138071-82-6) Production by Regions5.1.1 Global Gadobutrol (CAS 138071-82-6) Production by Regions 5.1.2 Global Gadobutrol (CAS 138071-82-6) Revenue by Regions 5.2 Gadobutrol (CAS 138071-82-6) Consumption by Regions 5.3 North America Gadobutrol (CAS 138071-82-6) Market Analysis5.3.1 North America Gadobutrol (CAS 138071-82-6) Production 5.3.2 North America Gadobutrol (CAS 138071-82-6) Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Gadobutrol (CAS 138071-82-6) Import and Export 5.4 Europe Gadobutrol (CAS 138071-82-6) Market Analysis5.4.1 Europe Gadobutrol (CAS 138071-82-6) Production 5.4.2 Europe Gadobutrol (CAS 138071-82-6) Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Gadobutrol (CAS 138071-82-6) Import and Export 5.5 China Gadobutrol (CAS 138071-82-6) Market Analysis5.5.1 China Gadobutrol (CAS 138071-82-6) Production 5.5.2 China Gadobutrol (CAS 138071-82-6) Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Gadobutrol (CAS 138071-82-6) Import and Export 5.6 Japan Gadobutrol (CAS 138071-82-6) Market Analysis5.6.1 Japan Gadobutrol (CAS 138071-82-6) Production 5.6.2 Japan Gadobutrol (CAS 138071-82-6) Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Gadobutrol (CAS 138071-82-6) Import and Export 5.7 Southeast Asia Gadobutrol (CAS 138071-82-6) Market Analysis5.7.1 Southeast Asia Gadobutrol (CAS 138071-82-6) Production 5.7.2 Southeast Asia Gadobutrol (CAS 138071-82-6) Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Gadobutrol (CAS 138071-82-6) Import and Export 5.8 India Gadobutrol (CAS 138071-82-6) Market Analysis5.8.1 India Gadobutrol (CAS 138071-82-6) Production 5.8.2 India Gadobutrol (CAS 138071-82-6) Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Gadobutrol (CAS 138071-82-6) Import and Export 6 Gadobutrol (CAS 138071-82-6) Segment Market Analysis (by Type) 6.1 Global Gadobutrol (CAS 138071-82-6) Production by Type 6.2 Global Gadobutrol (CAS 138071-82-6) Revenue by Type 6.3 Gadobutrol (CAS 138071-82-6) Price by Type 7 Gadobutrol (CAS 138071-82-6) Segment Market Analysis (by Application) 7.1 Global Gadobutrol (CAS 138071-82-6) Consumption by Application 7.2 Global Gadobutrol (CAS 138071-82-6) Consumption Market Share by Application (2014-2019) 8 Gadobutrol (CAS 138071-82-6) Major Manufacturers Analysis 8.1 Bayer HealthCare Pharmaceuticals Inc.8.1.1 Bayer HealthCare Pharmaceuticals Inc. Gadobutrol (CAS 138071-82-6) Production Sites and Area Served 8.1.2 Bayer HealthCare Pharmaceuticals Inc. Product Introduction, Application and Specification 8.1.3 Bayer HealthCare Pharmaceuticals Inc. Gadobutrol (CAS 138071-82-6) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 SWAPNROOP DRUGS & PHARMACEUTICALS8.2.1 SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Production Sites and Area Served 8.2.2 SWAPNROOP DRUGS & PHARMACEUTICALS Product Introduction, Application and Specification 8.2.3 SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 Manus Aktteva Biopharma LLP8.3.1 Manus Aktteva Biopharma LLP Gadobutrol (CAS 138071-82-6) Production Sites and Area Served 8.3.2 Manus Aktteva Biopharma LLP Product Introduction, Application and Specification 8.3.3 Manus Aktteva Biopharma LLP Gadobutrol (CAS 138071-82-6) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Jilin Tely Imp & Exp CO.,LTD8.4.1 Jilin Tely Imp & Exp CO.,LTD Gadobutrol (CAS 138071-82-6) Production Sites and Area Served 8.4.2 Jilin Tely Imp & Exp CO.,LTD Product Introduction, Application and Specification 8.4.3 Jilin Tely Imp & Exp CO.,LTD Gadobutrol (CAS 138071-82-6) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 JinYan Chemicals (ShangHai) Co., Ltd.8.5.1 JinYan Chemicals (ShangHai) Co., Ltd. Gadobutrol (CAS 138071-82-6) Production Sites and Area Served 8.5.2 JinYan Chemicals (ShangHai) Co., Ltd. Product Introduction, Application and Specification 8.5.3 JinYan Chemicals (ShangHai) Co., Ltd. Gadobutrol (CAS 138071-82-6) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 BOC Sciences8.6.1 BOC Sciences Gadobutrol (CAS 138071-82-6) Production Sites and Area Served 8.6.2 BOC Sciences Product Introduction, Application and Specification 8.6.3 BOC Sciences Gadobutrol (CAS 138071-82-6) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 8.7 LGM Pharma8.7.1 LGM Pharma Gadobutrol (CAS 138071-82-6) Production Sites and Area Served 8.7.2 LGM Pharma Product Introduction, Application and Specification 8.7.3 LGM Pharma Gadobutrol (CAS 138071-82-6) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.7.4 Main Business and Markets Served 8.8 Advanced Technology & Industrail Co., Ltd.8.8.1 Advanced Technology & Industrail Co., Ltd. Gadobutrol (CAS 138071-82-6) Production Sites and Area Served 8.8.2 Advanced Technology & Industrail Co., Ltd. Product Introduction, Application and Specification 8.8.3 Advanced Technology & Industrail Co., Ltd. Gadobutrol (CAS 138071-82-6) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.8.4 Main Business and Markets Served 8.9 MedKoo Biosciences, Inc.8.9.1 MedKoo Biosciences, Inc. Gadobutrol (CAS 138071-82-6) Production Sites and Area Served 8.9.2 MedKoo Biosciences, Inc. Product Introduction, Application and Specification 8.9.3 MedKoo Biosciences, Inc. Gadobutrol (CAS 138071-82-6) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.9.4 Main Business and Markets Served 9 Development Trend of Analysis of Gadobutrol (CAS 138071-82-6) Market 9.1 Global Gadobutrol (CAS 138071-82-6) Market Trend Analysis9.1.1 Global Gadobutrol (CAS 138071-82-6) Market Size (Volume and Value) Forecast 2019-2025 9.2 Gadobutrol (CAS 138071-82-6) Regional Market Trend9.2.1 North America Gadobutrol (CAS 138071-82-6) Forecast 2019-2025 9.2.2 Europe Gadobutrol (CAS 138071-82-6) Forecast 2019-2025 9.2.3 China Gadobutrol (CAS 138071-82-6) Forecast 2019-2025 9.2.4 Japan Gadobutrol (CAS 138071-82-6) Forecast 2019-2025 9.2.5 Southeast Asia Gadobutrol (CAS 138071-82-6) Forecast 2019-2025 9.2.6 India Gadobutrol (CAS 138071-82-6) Forecast 2019-2025 9.3 Gadobutrol (CAS 138071-82-6) Market Trend (Product Type) 9.4 Gadobutrol (CAS 138071-82-6) Market Trend (Application) 10.1 Marketing Channel10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Gadobutrol (CAS 138071-82-6) Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List
Summary: Get latest Market Research Reports on Gadobutrol (CAS 138071-82-6) Market Professional Survey Report 2019. Industry analysis & Market Report on Gadobutrol (CAS 138071-82-6) Market Professional Survey Report 2019 is a syndicated market report, published as Global Gadobutrol (CAS 138071-82-6) Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Gadobutrol (CAS 138071-82-6) Market Professional Survey Report 2019 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
Last updated on 28 January, 2019